The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Irreversible electroporation (IRE) for treating renal cancer.
Renal cancer occurs in the lining of the very small tubes in the kidney. Irreversible electroporation is a process that uses electrical pulses to kill cancer cells; it is applied directly to the tumour through special needles.
M13.8 Other specified percutaneous puncture of kidney
Y12.3 Electrochemotherapy to lesion of organ NOC
Y53.- Approach to organ under image control
In addition ICD-10 code C64.X Malignant neoplasm of kidney, except renal pelvis or C65.X Malignant neoplasm of renal pelvis or C79.0 Secondary malignant neoplasm of kidney and renal pelvis is assigned.
The NHS Classifications Service has advised NICE that currently these are the most suitable OPCS-4 codes to describe this procedure. The OPCS-4 classification is designed to categorise procedures for analysis and it is not always possible to identify a procedure uniquely.
The NHS Classifications Service of the Health and Social Care Information Centre is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. http://systems.hscic.gov.uk/data/clinicalcoding